Chatham Capital Group’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$208K Buy
+939
New +$205K 0.03% 202
2026
Q2
– Sell
-1,100
Closed -$247K – 205
2026
Q1
$247K Hold
1,100
– – 0.04% 191
2025
Q4
$265K Hold
1,100
– – 0.04% 190
2025
Q3
$301K Hold
1,100
– – 0.04% 184
2025
Q2
$284K Sell
1,100
-150
-12% -$35.8K 0.04% 185
2025
Q1
$280K Hold
1,250
– – 0.05% 182
2024
Q4
$286K Hold
1,250
– – 0.05% 180
2024
Q3
$305K Hold
1,250
– – 0.05% 173
2024
Q2
$239K Hold
1,250
– – 0.04% 180
2024
Q1
$248K Hold
1,250
– – 0.05% 179
2023
Q4
$215K Buy
+1,250
New +$192K 0.04% 178
2023
Q3
– Sell
-1,250
Closed -$273K – 190
2023
Q2
$273K Hold
1,250
– – 0.06% 172
2023
Q1
$274K Hold
1,250
– – 0.06% 170
2022
Q4
$260K Hold
1,250
– – 0.06% 171
2022
Q3
$273K Hold
1,250
– – 0.07% 161
2022
Q2
$262K Hold
1,250
– – 0.06% 168
2022
Q1
$303K Sell
1,250
-740
-37% -$179K 0.06% 160
2021
Q4
$518K Hold
1,990
– – 0.09% 145
2021
Q3
$524K Hold
1,990
– – 0.1% 142
2021
Q2
$491K Hold
1,990
– – 0.09% 141
2021
Q1
$386K Hold
1,990
– – 0.08% 145
2020
Q4
$423K Hold
1,990
– – 0.1% 135
2020
Q3
$341K Hold
1,990
– – 0.08% 131
2020
Q2
$382K Sell
1,990
-350
-15% -$57.3K 0.1% 126
2020
Q1
$345K Hold
2,340
– – 0.1% 131
2019
Q4
$363K Hold
2,340
– – 0.09% 137
2019
Q3
$316K Hold
2,340
– – 0.08% 137
2019
Q2
$286K Hold
2,340
– – 0.07% 145
2019
Q1
$243K Hold
2,340
– – 0.06% 147
2018
Q4
$266K Hold
2,340
– – 0.07% 141
2018
Q3
$270K Hold
2,340
– – 0.07% 133
2018
Q2
$242K Hold
2,340
– – 0.06% 139
2018
Q1
$230K Buy
+2,340
New +$221K 0.06% 137
2017
Q2
– Sell
-21,405
Closed -$1.54M – 155
2017
Q1
$1.54M Sell
21,405
-2,040
-9% -$141K 0.43% 48
2016
Q4
$1.46M Buy
23,445
+4,400
+23% +$269K 0.42% 55
2016
Q3
$1.23M Sell
19,045
-750
-4% -$49.9K 0.39% 50
2016
Q2
$1.25M Hold
19,795
– – 0.39% 49
2016
Q1
$1.14M Sell
19,795
-400
-2% -$22.6K 0.36% 54
2015
Q4
$1.08M Hold
20,195
– – 0.35% 60
2015
Q3
$1.03M Sell
20,195
-250
-1% -$13.5K 0.35% 59
2015
Q2
$1.15M Hold
20,445
– – 0.32% 63
2015
Q1
$1.47M Buy
20,445
+550
+3% +$35.7K 0.43% 50
2014
Q4
$1.12M Hold
19,895
– – 0.33% 60
2014
Q3
$980K Buy
19,895
+200
+1% +$10.2K 0.3% 68
2014
Q2
$997K Hold
19,695
– – 0.39% 57
2014
Q1
$880K Hold
19,695
– – 0.36% 58
2013
Q4
$927K Hold
19,695
– – 0.39% 59
2013
Q3
$1.04M Hold
19,695
– – 0.47% 47
2013
Q2
$889K Buy
+19,695
New +$934K 0.43% 49

Other funds holding RMD

Chatham Capital Group's RMD Position: Q3 2026 in Review

Chatham Capital Group opened a new position in ResMed (RMD) in Q3 2026: 939 shares worth $208K. The stake represents 0.03% of the portfolio and ranks #202 among its holdings. This is a return to the name: Chatham Capital Group previously reported a position in RMD as recently as Q1 2026.

Chatham Capital Group first reported a position in RMD in Q2 2013 and has held it in 49 quarters since. The position peaked at $1.54M in Q1 2017. 886 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Chatham Capital Group held 939 shares of ResMed worth $208K as of Q3 2026.
  • ResMed was a new Chatham Capital Group position in Q3 2026.
  • ResMed made up 0.03% of Chatham Capital Group's portfolio in Q3 2026, its #202 holding.
  • Chatham Capital Group first reported a position in ResMed in Q2 2013 and has held it in 49 quarters since.
  • Chatham Capital Group's ResMed position peaked at $1.54M in Q1 2017.
  • 886 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Chatham Capital Group's 13F filing for Q3 2026, filed 16 Oct 2026.